Boston Scientific said on Tuesday it had experienced a cybersecurity incident affecting certain information technology systems, leading to disruptions in operations and limiting access to business applications. The company noted that the incident had impacted its ability to process and ship customer orders, with disruptions expected to continue.
The medical device maker initiated an investigation with the assistance of third-party cybersecurity experts to assess and contain the threat. As of the disclosure, the full scope of the incident and its potential material impact remained unknown, along with the timeline for full system restoration.
Shares of Boston Scientific fell 4% in premarket trading on Wednesday following the announcement.
